INTRODUCTION
Rheumatoid arthritis ,an auto immune disease causing degenerative joint changes resulting in deformity and movement restriction with agonizing pain ful movement at joints, thus make the person crippled or handicap even for their routine activities 1, 2 .. This affect 0.5%-1% people of the developed world and 5-50 cases every lakh population in added every year. Onset during middle age is more common and women are affected 2.5 times more than men 1 . The pain associated with Ra is induced at the site of inflammation and termed as Nociceptive than neuropathic. Glycan (Oligo saccharide ) alteration causes joint inflammation. Plasma cell derived from B lymphocytes produces Rh factor,ACPA of the IgG and IgM type in large quantity. 2 The goal of treatment is to alleviate pain, decrease inflammation and improve functional capabilities. Commonly used therapeutics constitutes Analgesic, Steroid and disease modifying anti rheumatoid drugs (DMARDs) 3, 4 fail to ensure cure or complete symptomatic relief . Considering its auto immune pathogenesis, a biological regime constituting Self blood 2 ml with Betamethasone been evaluated in non diabetic rheumatoid arthritis cases.
MATERIAL & METHODS
Patients of rheumatoid arthritis diagnosed on the basis of clinical presentation and confirmed by serological & radiological evaluation, non responsive to the conventional anti rheumatoid regimes were selected to evaluate the clinical efficacy and safety profile of Self blood with Betamethasone intramuscular in non diabetic or controlled diabetic patients.
Each selected patients were interrogated for the history of disease, therapeutics consumed and their clinical response and were examined thoroughly to evaluate the quality of life and movement at the joints.
All patients were serologically evaluated for Rheumatoid factor, C-reactive protein, Anti nuclear antibody (ANA), Renal function test, hepatic enzymes, hematological values and radiological examination for joint status. In addition each patients were assessed for pre and post therapy (after 6 month) for hematological and hepato renal parameters.
Based on the therapeutic status and clinical presentation, patients were classified in to the following grade of severity 
OBSERVATIONS
Among the selected 210 patients of non diabetic non hypertensive RA, 60 were male and 150 were female of age group 35-55 yrs. (Table -1 
Table1. Shows distribution of patients as per age and sex

Age group A Number of patients (in yrs)
Male Female Total  35-40  24  52  76  40-45  16  38  54  45-50  11  34  45  50-55  09  26  35 Pie diagram showing sex wise composition:
Common presentation i.e.-agonizing joint pain, swelling of the joint and physical in capabilities were common among all whereas 190 cases had wasting and worst and poor quality of life in 70 and 40 cases respectively (Table - All selected patients reveal raised C reactive protein, Rheumatoid factor, Erythrocyte sedimentation rate and radiological appearance shows joint deformity (Table-5) 
